Global Longevity Diagnostics Market Size & Outlook
Global longevity diagnostics market, 2021-2033 (US$M)
Related Markets
Global longevity diagnostics market highlights
- The global longevity diagnostics market generated a revenue of USD 2,796.2 million in 2025 and is expected to reach USD 4,536.1 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 6.4% by 2033.
- In terms of segment, epigenetic age testing accounted for a revenue of USD 760.6 million in 2025.
- Multi-Omics Profiling is the most lucrative test type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 2,796.2 million |
| Market revenue in 2033 | USD 4,536.1 million |
| Growth rate | 6.4% (CAGR from 2026 to 2033) |
| Largest segment | Epigenetic age testing |
| Fastest growing segment | Multi-Omics Profiling |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Epigenetic Age Testing, Telomere Length Analysis, Multi-Omics Profiling, Proteomics-Based Aging Biomarkers, Metabolomics Testing, Microbiome Aging Diagnostics, Hormone & Metabolic Profiling |
Other key industry trends
- In terms of revenue, the North America accounted for 47.3% of the global longevity diagnostics market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 197.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Longevity Diagnostics Market Scope
Longevity Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Altos Labs | View profile | 251-500 | San Francisco, California, United States, North America | https://altoslabs.com/ |
| WellnessFX | View profile | 11-50 | San Francisco, California, United States, North America | https://www.wellnessfx.com |
| Function Health | View profile | 11-50 | Austin, Texas, United States, North America | https://www.functionhealth.com |
| InsideTracker | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | http://insideTracker.com |
| Tally Health | View profile | 11-50 | New York, New York, United States, North America | https://www.tallyhealth.com |
| GlycanAge | View profile | 11-50 | Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom, Europe | https://glycanage.com |
| TruDiagnostic | View profile | 51-100 | Lexington, Kentucky, United States, North America | https://trudiagnostic.com |
| SiPhox Health | View profile | 11-50 | Burlington, Massachusetts, United States, North America | https://siphoxhealth.com |
| Elysium | View profile | 11-50 | New York, New York, United States, North America | http://www.elysiumhealth.com |
| Abbott | View profile | - | - | - |
| Nebula Genomics | View profile | 11-50 | San Francisco, California, United States, North America | https://www.nebula.org |
| Knovos | View profile | 251-500 | Fairfax, Virginia, United States, North America | https://www.knovos.com/ |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | https://www.23andme.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
Global longevity diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to longevity diagnostics market will help companies and investors design strategic landscapes.
Epigenetic age testing was the largest segment with a revenue share of 27.2% in 2025. Horizon Databook has segmented the Global longevity diagnostics market based on epigenetic age testing, telomere length analysis, multi-omics profiling, proteomics-based aging biomarkers, metabolomics testing, microbiome aging diagnostics, hormone & metabolic profiling covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Longevity Diagnostics Test Type Outlook (Revenue, USD Million, 2021-2033)
- Epigenetic Age Testing
- Telomere Length Analysis
- Multi-Omics Profiling
- Proteomics-Based Aging Biomarkers
- Metabolomics Testing
- Microbiome Aging Diagnostics
- Hormone & Metabolic Profiling
- Global Longevity Diagnostics Technology Outlook (Revenue, USD Million, 2021-2033)
- Next-Generation Sequencing (NGS)
- Mass Spectrometry
- AI-Powered Analytics
- Microarray Technology
- Wearable-Integrated Monitoring
- Global Longevity Diagnostics End Use Outlook (Revenue, USD Million, 2021-2033)
- Direct-to-Consumer (DTC)
- Longevity Clinics
- Hospitals & Clinical Laboratories
- Others
Reasons to subscribe to Global longevity diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global longevity diagnostics market databook
-
Our clientele includes a mix of longevity diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global longevity diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global longevity diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global longevity diagnostics market size, by regions, 2021-2033 (US$M)
Top 10 countries: Longevity diagnostics market size, 2025 (US$M)
Global longevity diagnostics market share, by test type, 2025 & 2033 (%, US$M)
Longevity diagnostics market: Opportunity assessment by country
Global longevity diagnostics market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
